Exelixis, Inc. (EXEL) vs Solventum Corporation (SOLV)
A side-by-side comparison of Exelixis, Inc. and Solventum Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EXEL
Exelixis, Inc.
$58.85HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
SOLV
Solventum Corporation
$88.03HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — EXEL vs SOLV
growth of $100 · dividends reinvested · last 3yEXEL +147.5% (+35.3%/yr)SOLV +10.0% (+3.2%/yr)EXEL compounded faster over this window
EXEL SOLV
EXEL vs SOLV: by the numbers
- •SOLV is the larger company ($15.24B vs $14.79B market cap).
- •SOLV trades at the lower trailing earnings multiple (10.75 vs 18.45 P/E), one valuation lens rather than an overall verdict.
- •EXEL converts more revenue to profit (35.33% vs 17.26% net margin).
- •EXEL grew revenue faster over the past five years (16.06% vs 2.72% CAGR).
Metrics side by side
Valuation
| Metric | EXEL | SOLV |
|---|---|---|
| P/E ratio | 18.45 | 10.75 |
| Forward P/E | 16.75 | 12.29 |
| PEG ratio | 0.36 | 1.76 |
| P/S ratio | 6.07 | 1.83 |
| P/B ratio | 8.02 | 3.18 |
| EV / EBITDA | 14.68 | 7.07 |
| FCF yield | 7.83% | N/A |
Profitability
| Metric | EXEL | SOLV |
|---|---|---|
| Gross margin | 96.48% | 54.69% |
| Operating margin | 39.88% | 24.99% |
| Net margin | 35.33% | 17.26% |
| ROE | 46.68% | 29.88% |
| ROIC | 37.87% | 15.85% |
Growth (annualized)
| Metric | EXEL | SOLV |
|---|---|---|
| Revenue CAGR (5Y) | 16.06% | 2.72% |
| EPS CAGR (5Y) | 51.51% | 6.26% |
| FCF CAGR (5Y) | 39.63% | N/A |
| Total return CAGR (5Y) | 23.00% | N/A |
Frequently asked
- Which has the lower trailing P/E, EXEL or SOLV?
- SOLV has the lower trailing P/E: EXEL trades at 18.45 and SOLV at 10.75. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, EXEL or SOLV?
- Over the past five years, EXEL grew revenue faster — EXEL at a 16.06% CAGR versus SOLV at 2.72%.
- Is EXEL or SOLV more profitable?
- EXEL runs the higher net margin — EXEL at 35.33% versus SOLV at 17.26%.
Go deeper
Dig into the metrics
Exelixis P/E ratioSolventum P/E ratioExelixis ROESolventum ROEExelixis operating marginSolventum operating marginExelixis revenue growthSolventum revenue growthExelixis free cash flowSolventum free cash flow
Exelixis & Solventum appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.